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Introduction
Lhermitte–Duclos disease (LDD) is a rare benign lesion
of the cerebellum. The disease is characterized by a cere-
bellar mass composed of enlarged cerebellar folia con-
taining abnormal ganglion cells. It usually presents in
young and middle-aged adults, commonly with a symp-
tom of intracranial hypertension and cerebellar signs.
However, it may remain asymptomatic until incidentally
discovered at autopsy or by imaging study for an unre-
lated condition.
We present a case of LDD and describe the magnetic
resonance imaging (MRI) signal characteristics and
magnetic resonance spectroscopy (MRS) to confirm the
relatively benign hamartomatous nature of this lesion.
Case Report
A 22-year-old man was generally well before admis-
sion to a local hospital for the treatment of right
lower limb fracture sustained in a traffic accident. He
denied any previous experience of abnormal gait and
visual or hearing impairment. On admission, neurologic
examination revealed no evidence of focal sensory or
motor dysfunction. Unfortunately, brain computed
tomography (CT) for survey revealed a space-occupying
lesion in the right cerebellar hemisphere. The patient
was subsequently transferred to our hospital for pre-
operative MRI study. All MRI images were acquired 
at 1.5T (Sonata, Siemens Medical Systems, Germany).
The multisequence and multiplanar images, including
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T1-weighted, T2-weighted, fluid-attenuated inver-
sion recovery (FLAIR), and diffusion-weighted were
obtained, followed by gadolinium-diethylenetriamine-
pentaacetic acid (Gd-DTPA) contrast administration
intravenously. In addition, proton MRS was performed.
Spectroscopic data were acquired from the patient’s
cerebellar abnormality using a single-voxel (8 mL),
point-resolved (PRESS) technique (TR/TE/NEX:
1,500/135/2). Spectral postprocessing was per-
formed using the software provided by the MR system
manufacturer.
MRI demonstrated a large mass lesion about 4.5 ×
5 × 4.5 cm in the right cerebellar hemisphere. It was well
circumscribed, with high signal intensity with respect
to cerebellar white matter on FLAIR images (Figure
1A) and a striated pattern of high signal intensity on
T2-weighted images (Figure 1B). The striations of the
lesion were isointense to cerebellar gray matter on T2-
weighted images and corresponded to the striated pat-
tern with low signal intensity on T1-weighted images
(Figure 1C). There was no obvious enhancement of the
lesion following administration of GD-DTPA intra-
venously (Figure 1D). The mass appeared diffusely
bright on diffusion-weighted images, whereas apparent
diffusion coefficient (ADC) mapping revealed no restric-
tion of water diffusion (Figure 2). Proton MRS showed
an elevated lactate peak at 1.33 ppm, and association of
decreased ratios in N-acetylaspartate/creatine (NAA/
Cr) (1.2) and NAA/choline (Cho) (1.6), with near
normal values of Cho/Cr (0.75) (Figure 3).
Because the patient was afraid of malignancy,
subtotal resection of the tumor for tissue proof was
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Figure 1. (A) Axial fluid-attenuated inversion recovery image [TR/TE/TI/NEX: 9,000/119/2,500/2] demonstrated a well-circumscribed
mass about 4.5 × 5 × 4.5 cm in size in the right cerebellar hemisphere (arrow) with high signal intensity with respect to cerebellar white
matter. (B) Axial T2-weighted image [TR/TE/NEX: 4,220/94/2] demonstrated a high signal intensity mass lesion with the characteristic
striped appearance (arrowheads) in the right cerebellar hemisphere. (C) Axial T1-weighted image [TR/TE/NEX: 587/13/2] demon-
strated a low signal intensity mass with multiple enlarged folia forming a characteristic striped appearance (arrow). (D) Sagittal 
T1-weighted image following administration of Gd-DTPA [TR/TE/NEX: 587/13/2]. A non-enhancing low signal intensity mass lesion (arrow)
in the right cerebellar hemisphere was illustrated.
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requested. After right paramedian suboccipital craniec-
tomy was performed, moderate intracranial pressure
was measured before the dura was opened. Upon open-
ing of dura matter, a poorly-defined, whitish-brown
mass lesion with hypovascularity extending through-
out the right cerebellum was visualized. A specimen
measuring about 2.5 × 2 × 0.5 cm was taken out for
histopathologic examination. On gross examination,
the surgical specimen was characterized by thickening
of the cerebellar cortex. On histopathologic examination
of the tumor, we found that the granular layer had
disappeared and was completely replaced by large
ganglion-like neurons. Normal Purkinje’s cells, be-
tween molecular layer and granular layer, were also
absent (Figure 4). Those abnormal ganglion cells
aggregated in the fibrillary matrix without any inflam-
mation. After the pathologic diagnosis of LDD was
made, a series of studies, including a more detailed
BA
Figure 2. (A) Axial diffusion-weighted imaging performed using echoplanar sequence [TR/TE/NEX: 3,500/108/2, b = 1,000] demon-
strated high signal intensity within the lesion. (B) On the corresponding apparent diffusion coefficient map, the lesion demonstrated no
restriction of diffusion.
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Figure 3. Magnetic resonance spectroscopy [single-voxel (8 mL), PRESS technique (TR/TE/NEX: 1,500/135/2)] showed elevation of
lactate doublet at 1.33 ppm (arrow) and associations of decrease in the ratio of NAA/Cr (1.2) and NAA/Cho (1.6) with near normal 
values of Cho/Cr (0.75).
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physiologic examination to rule out Cowden disease,
were performed. But no other skin or mucous mem-
brane abnormality associated with Cowden disease or
multiple hamartoma syndromes could be identified.
Discussion
In 1920, Lhermitte–Duclos described an unusual
abnormality of the cerebellum, characterized by
enlarged cerebellar folia, which contained circum-
scribed regions of abnormal ganglion cells. The authors
originally described the lesion under the name of
“ganglioneurome myélinique diffuse de l’écore céré-
belleuse”.1 Subsequently, this disorder is now com-
monly classified as a diffuse ganglioneuroma of the
cerebellar cortex,2 (benign) hypertrophy of the cerebel-
lum,3 hamartoma of the cerebellum, gangliocytoma
myelinicum diffusum of the cerebellar cortex, dysplas-
tic gangliocytoma of the cerebellum, or simply LDD.
In the vast majority of cases, LDD manifests in
adulthood (usually in the 3rd or 4th decade of life),
but the age at presentation may vary from birth to the
6th decade. Patients with LDD may become sympto-
matic because of the mass effect from the lesion, with
resultant intracranial hypertension, and cerebellar
signs and symptoms. But LDD may remain asymp-
tomatic until incidentally discovered at autopsy or in
an imaging study for an unrelated condition. The dis-
ease is typically unilateral; however, LDD may extend
into the vermis or, more rarely, into the contralateral
hemisphere. Grossly, the tumor appearance is that of
expanded cerebellar folia that efface the sulci.4,5 The
histopathologic characteristics include a thick layer of
abnormal ganglion cells replacing the granular layer
of the cerebellar cortex, a thick hypermyelinated 
marginal layer, and a thin Purkinje’s cell layer with
thinning of medullary white matter. Numerous asso-
ciated abnormalities have been described in patients
with LDD. These include megalocephaly, microgyria,
spongioblastomas, peritheliomas, hydromyelia, partial
gigantism, hemangiomas, polydactyly, macroglossia,
and leontiasis ossea.6 Coexistence of Cowden disease
or multiple hamartoma syndromes, an autosomal dom-
inant disorder of the skin and mucous membranes,
with LDD has been described,7 suggesting that this
constellation of diseases represents a phakomatosis. In
this syndrome, thyroid disorders are also common,
and malignancies of the breast, colon and adnexa may
also occur.4
The neuroimaging feature of LDD on unenhanced
CT is hypoattenuating but may occasionally be isoat-
tenuating in posterior fossa. Due to the inherent beam-
hardening artifacts in the posterior fossa with CT, MRI
is certainly the imaging modality of choice. On T1-
weighted images, the striations have been described
as hypointense and isointense, respectively, to cerebel-
lar gray matter.8 On T2-weighted images, the lesions
are well circumscribed and have a unique striated pat-
tern consisting of alternating bands of high signal
intensity and normal signal intensity relative to cere-
bellar gray matter.9 The majority of lesions appear very
mild or with no enhancement following administra-
tion of intravenous Gd-DTPA. The lack of contrast
enhancement suggests insignificant disturbances of
the blood-brain barrier and/or absence of extracellu-
lar edema. The characteristic non-enhancing gyriform
patterns correspond to the enlargement of cerebellar
cortical folia. The enlarged folia lose their secondary
foldings and asymmetrically widen the affected cerebel-
lar hemisphere.10 Kulkantrakorn et al4 reported that
the high signal intensity band seen on T2-weighted
images corresponded to the inner molecular layer and
the granular cell layer. Loss of central white matter
within the folia also contributed to this appearance.
The outer portion of the folia consisting of the outer
molecular layer and leptomeninges within effaced sulci
created the band isointense to cerebellar gray matter on
T2-weighted images. On diffusion-weighted images,
the lesion was characterized by higher signal intensities
on diffusion-weighted images from T2 shine-through
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Figure 4. Photomicrograph of the fragmented brain tissue (hema-
toxylin and eosin stain, original magnification 40×) showed 3 visi-
ble layers of the normal cerebellum included the white matter
(W), the granular layer (G), and the molecular layer (M) of gray
matter. The thin Purkinje cell layer is between the granular layer
and molecular layer. The tumor part (arrowheads) which should
be the granular layer was replaced by a thick layer of abnormal
ganglion cells.
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effect, whereas ADC mapping showed no disturbance
of water diffusion.9 Two prior reports of 3 cases9,11
demonstrated the same characteristics of diffuse-
weighted images and ADC maps as our case. They
presumed that this might be due to hypercellularity
with diffuse replacement of the granular and Pukinje
cell layers with ganglion cells and dense collections of
axons throughout the molecular layer.11
Spectral peaks obtained from normal parenchyma
include those that represent NAA-containing com-
pounds (at 2.02 ppm), Cr (at 3.0 ppm), and Cho (at
3.2 ppm). The other peak, lactate, usually not detected
in normal parenchyma, appears as a doublet (at
1.3 ppm). Nagaraja et al12 reported that NAA/Cr and
NAA/Cho ratios in LDD represent a decrease in the
concentration of NAA, which could be attributed to a
lack of neuronal architecture (a hallmark of hamar-
toma) and/or the presence of embryonic neural tis-
sue, which fails to express NAA. If Cr is taken as an
internal standard, the near normal values of Cho/Cr
ratios in LDD indicate a lack of cell turnover or 
proliferation, and the pathology is unlikely to be
tumorous. These results are in favor of “benign”
hamartoma rather than a tumor.12 In other cerebral
neoplasia, a decrease in NAA or NAA/Cr ratio associ-
ated with an increase in Cho or Cho/Cr ratio is often
reported.13 This combination has also been described
in cerebellar tumors.14 On the other hand, decreased
Cho/Cr ratios are not observed in cerebral malignant
tumors, where increases in Cho levels are associated
with enhanced membrane turnover. Lactate, normally
undetectable in brain, accumulate in cysts, necrotic tis-
sue, or within active tumors because of the high rate
of glycolysis. Hence, the lactate peak suggests altered
anaerobic metabolism. Klisch et al9 and Nagaraja et al12
considered that the elevated lactate level is due to an
abnormal high glucose metabolism with the LDD,
rather than representing high lactate level in cystic or
necrotic components of LDD. Combined with the
histopathologic findings of no necrotic areas within
the LDD lesion, the elevated lactate levels do not re-
present cell death. Therefore, LDD has some character-
istics of tumors such as decreased NAA and increased
lactate, but not increased levels of Cho. In 1 of the 2
prior studies, Klisch et al9 also mentioned decreased
myoinositol/Cr ratio, and this finding was associated
with astrocyte marker or cell volume regularity. They
described that this peak could be visualized on shot
TE MRS sequence, not on long TE as in our routine
protocol.15
In conclusion, patients with LDD may demon-
strate the typical striated pattern of hyperintensity on
T2-weighted images and corresponding hypointensity
on T1-weighted images, as well as the typical absence
of enhancement following Gd-DTPA administra-
tion. In addition, the lack of restricted diffusion on
diffusion-weighted MRI, and associations of decreases
in the NAA/Cr and NAA/Cho ratios with near normal
values of Cho/Cr, as well as an obvious lactate peak
may suggest a benign hamartoma.
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